Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Katsui

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Radiotherapy for outpatients]K Karasawa, K Katsui, M Kohno, et al.
Anticancer Research|January 30, 2003
Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancerK Karasawa, H Shinoda, K Katsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 1999
[Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy]Y Kaneyasu, M Kita, K Katsui, et al.
ESMO Open|June 21, 2021
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II studyK Hotta, S Saeki, M Yamaguchi, et al.
ESMO Open|July 8, 2022
Corrigendum to 'Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study': [ESMO Open Volume 6, Issue 4, August 2021, 100191]K Hotta, S Saeki, M Yamaguchi, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 1, 2000
[Radiotherapy for outpatients]K Karasawa, K Katsui, M Kohno, et al.
Anticancer Research|January 30, 2003
Radiotherapy with concurrent docetaxel and carboplatin for head and neck cancerK Karasawa, H Shinoda, K Katsui, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|November 24, 1999
[Effectiveness of 3 ways method in intra-arterial infusion chemotherapy for advanced or recurrent cervical cancer with or without radiotherapy]Y Kaneyasu, M Kita, K Katsui, et al.
ESMO Open|June 21, 2021
Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II studyK Hotta, S Saeki, M Yamaguchi, et al.
ESMO Open|July 8, 2022
Corrigendum to 'Gefitinib induction followed by chemoradiotherapy in EGFR-mutant, locally advanced non-small-cell lung cancer: LOGIK0902/OLCSG0905 phase II study': [ESMO Open Volume 6, Issue 4, August 2021, 100191]K Hotta, S Saeki, M Yamaguchi, et al.
Pageof 1